AXILARIM Trademark

Trademark Overview

On Thursday, March 29, 2018, a trademark application was filed for AXILARIM with the United States Patent and Trademark Office. The USPTO has given the AXILARIM trademark a serial number of 87855481. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by Zosano Pharma Corporation. The AXILARIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraines and headaches
axilarim

General Information

Serial Number87855481
Word MarkAXILARIM
Filing DateThursday, March 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of migraines and headaches

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZosano Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFremont, CA 94555
Party NameZosano Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFremont, CA 94555

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, September 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 9, 2021SOU EXTENSION 5 GRANTED
Wednesday, September 1, 2021SOU EXTENSION 5 FILED
Thursday, September 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 1, 2021SOU TEAS EXTENSION RECEIVED
Saturday, March 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 4, 2021SOU EXTENSION 4 GRANTED
Thursday, March 4, 2021SOU EXTENSION 4 FILED
Thursday, March 4, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2020SOU EXTENSION 3 GRANTED
Thursday, October 1, 2020SOU EXTENSION 3 FILED
Thursday, October 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 14, 2020SOU EXTENSION 2 GRANTED
Friday, February 14, 2020SOU EXTENSION 2 FILED
Friday, February 14, 2020SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2019SOU EXTENSION 1 GRANTED
Tuesday, September 17, 2019SOU EXTENSION 1 FILED
Tuesday, September 17, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 12, 2018NON-FINAL ACTION E-MAILED
Thursday, July 12, 2018NON-FINAL ACTION WRITTEN
Thursday, July 12, 2018ASSIGNED TO EXAMINER
Thursday, April 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 2, 2018NEW APPLICATION ENTERED

Related Keywords

axilarim headaches migraines treatment preparations pharmaceutical